Red Nucleus
Red Nucleus, a leading provider of innovative learning solutions, is headquartered in the United States and operates across major regions including North America and Europe. Founded in 2015, the company has quickly established itself within the life sciences industry, specialising in medical education, training, and digital content development. The firm offers a unique blend of services, including custom eLearning, virtual reality training, and strategic consulting, all designed to enhance the educational experience for healthcare professionals. Red Nucleus is recognised for its commitment to quality and innovation, positioning itself as a trusted partner for pharmaceutical and biotechnology companies. With a focus on delivering impactful learning experiences, Red Nucleus has achieved notable milestones, including multiple industry awards that underscore its market leadership and dedication to excellence in the life sciences sector.
DitchCarbon Score
How does Red Nucleus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Red Nucleus's score of 8 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Red Nucleus's reported carbon emissions
Red Nucleus, headquartered in the United States, has made significant commitments towards achieving net-zero carbon emissions by 2050. Although specific emissions data for the most recent year is not available, the company has established long-term targets under the Science Based Targets initiative (SBTi) to address emissions across all scopes (Scope 1, 2, and 3). As of July 2023, Red Nucleus is committed to reducing its carbon footprint and has set a net-zero target, demonstrating its dedication to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. The company is actively working towards these goals, with a clear timeline extending to 2050, although specific reduction percentages have not been disclosed. By committing to these ambitious climate targets, Red Nucleus is positioning itself as a responsible leader in the industry, aiming to mitigate its environmental impact and contribute to global efforts against climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Red Nucleus is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
